Effects of rIFN-β-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells

Journal of NeuroVirology

Volumn 6, Issue SUPPL. 2, 2000, Pages

  Trojano, Maria ^a   Defazio, Giovanni ^a   Avolio, Carlo ^a   Paolicelli, Damiano ^a   Giuliani, Fabrizio ^a   Giorelli, Maurizio ^a   Livrea, Paolo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Brain microvascular endothelial cells culture; Membrane bound ICAM 1; Multiple sclerosis; rIFN 1b; Soluble ICAM 1

Indexed keywords

GADOLINIUM; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON BETA SERINE; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; AREA UNDER THE CURVE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CELL CULTURE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MONOLAYER CULTURE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR ENDOTHELIUM;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; GADOLINIUM; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-BETA; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RATS; SOLUBILITY;

ANIMALIA;

EID: 0034083037     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Calabresi PA, Pelfrey CM, Tranquill LR, Maloni H, McFarland HF (1997a). VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta. Neurology 49: 1111-1116.
2. Calabresi PA, Tranquill LR, Dambrosia JM, Stone LA, Maloni H, Bash CN, Frank JA, McFarland HF (1997b). Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with Interferon β-1b. Ann Neurol 41: 669-674.
3. Carson MP, Haudenschild C (1986). Microvascular endothelium and pericytes: high yield, low passage cultures. In Vitro Cell Dev Bio 22: 344-354.
4. Defazio G, Trojano M, Ribatti D, Nico B, Giorelli M, De Salvia R, Russo G, Roncali L, Livrea P (1998). Expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to Interferon β-1a and TNFα. J Neuroimmunol 88: 11-30.
5. The IFNβ MS Study Group (1993). Interferon β 1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double blind placebo controlled trial. Neurology 43: 655-661.
6. Jacobs LD, the Multiple Sclerosis Collaborative Research Group (1996). Intramuscular Interferon β-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 39: 285-294.
7. Kallmann BA, Hummel V, Rieckmann P (1998). Human cerebral endothelial cells are a major source of soluble cellular adhesion molecules during inflammatory conditions. Neurology 50: A111.
8. Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, Rudge P, McDonald WI (1990). Breakdown of the blood brain barrier precedes symptoms and othe MRI signs of new lesions in multiple sclerosis. Brain 113: 1477-1489.
9. King PD, Sandberg ET, Selvakumar A, Fang P, Beaudet AL, Dupont B (1995). Novel isoforms of murine intercellular adhesion molecule-1 generate by alternate RNA splicing. J Immunol 154: 6080-6093.
10. Kurtzke JF (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
11. Liu C, Li Wan Po A, Blumhardt L (1998). "Summary measure" statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 64: 726-729.
12. Miller A, Lanir N, Shapiro S, Revel M, Honigman S, Kinarty A, Lahat N (1996). Immunoregulatory effects of interferon-β and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis and other autoimmune diseases. J Neuroimmunol 64: 151-161.
13. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocol. Ann Neurol 13: 227-231.
14. PRISMS Study Group (1998). Randomised double-blind placebo-controlled study of interferon β-1a in relapsing-remitting multiple sclerosis. The Lancet 352: 1498-1504.
15. Raine CS (1991). Demyelinating diseases. In: Textbook of Neuropathology, 2nd edn. Davis RL, Robertson DM, (eds). Baltimore: William and Wilkins, pp. 535-620.
16. Rieckmann P, Michel U, Albrecht M, Bruck W Wockel L, Felghenhauer K (1995). Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol 60: 9-15.
17. Rokhlin OW, Cohen MB (1996). Soluble form of CD44 and CD54 (ICAM-1) cellular adhesion molecules are released by human prostatic cancer cell lines. Cancer Lett 107: 29-35.
18. Sharief MK, Thompson EJ (1992). In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol 38: 27-34.
19. Soilu-Hanninen M, Salmi A, Salonen R (1995). Interferon-β downregulates expression of VLA-4 antigen and antagonized interferon-γ-induced expression of HLA-DQ on human peripheral blood monocytes. J Neuroimmunol 60: 99-106.
20. Stone LA, Frank JA, Albert PS, Bash C, Smith ME, Maloni H, McFarland HF (1995). The effects of Interferon-β on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic rasonance imaging in relapsing-remitting multiple sclerosis. Ann Neurol 37: 611-619.
21. Trojano M, Avolio C, Simone IL, Defazio G, Manzari C, De Robertis F, Calò A, Livrea P (1996). Soluble intercellular adhesion molecule-1 in seram and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings. Neurology 47: 1535-1541.
22. Wong D, Dorovini-Zis K (1992). Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J Neuroimmunol 39: 11-22.